GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD

By | News | No Comments

ROCKVILLE, Md., May 1, 2017 /PRNewswire/ — GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.

Read More

View Original Article »

Hundreds Attend Biohealth Capital Region Forum in Gaithersburg

By | News | No Comments

Local business leaders, elected officials, scientists and scholars attended the 2017 BioHealth Capital Region Forum at the campus of MedImmune in Gaithersburg on April 19 and 20th. The forum focuses on the biotechnology cluster in Maryland, Virginia, and Washington, D.C., which is working collaboratively to become a top three biotech hub in the United States by 2023.

Read More

View Original Article »

BioHealth Acceleration Initiative

By | News | No Comments

The Maryland Life Sciences Advisory Board (LSAB) was created by the legislature in 2007 to assist in maintaining Maryland’s preeminence in the life sciences industry. Comprised of 18 members, the Board includes the Secretary of the Maryland Department of Commerce, a representative designated by the Maryland Technology Development Corporation (TEDCO), and 16 members appointed by the Governor.

Read More

View Original Article »

Senator Van Hollen speaks at Biohealth Forum

By | News | No Comments

GAITHERSBURG, Md. – The Biohealth Capital Region Forum continued Thursday in Gaithersburg where guests heard from Senator Chris Van Hollen.

One of the topics of the forum was funding for the biotech industry. Many national health companies are headquartered in Montgomery County and are concerned about federal funding. President Trump’s proposed budget would cut six billion dollars from the National Institute of Health.

Read More

View Original Article »

BioHealth Acceleration Initiative

By | Reports | No Comments

The Maryland Life Sciences Advisory Board (LSAB) was created by the legislature in 2007 to assist in maintaining Maryland’s preeminence in the life sciences industry. Comprised of 18 members, the Board includes the Secretary of the Maryland Department of Commerce, a representative designated by the Maryland Technology Development Corporation (TEDCO), and 16 members appointed by the Governor.

Read More

Center for Innovation Technology

By | Partner News | No Comments

The Center for Innovative Technology (CIT) creates technology-based economic development strategies to accelerate innovation, imagination and the next generation of technology and technology companies. Created in 1985, CIT, a non-profit corporation, plugs gaps at the earliest stages of the Innovation Continuum – commercialization and seed funding – as it helps entrepreneurs launch and grow high-growth technology companies and create high-paying jobs for the future. To facilitate national innovation leadership and accelerate the rate of technology adoption, CIT creates partnerships between innovative technology start-up companies and advanced technology consumers. Lastly, CIT builds the infrastructure for new innovation economies with expert broadband strategies.

Join our Mailing List